Aortic Regurgitation Disease Clinical Trials

7 recruiting

Aortic Regurgitation Disease Trials at a Glance

7 actively recruiting trials for aortic regurgitation disease are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in São Paulo, Frankfurt am Main, and Hamburg. Lead sponsors running aortic regurgitation disease studies include Chinese University of Hong Kong, IRCCS Policlinico S. Donato, and Anhui Provincial Cancer Hospital.

Browse aortic regurgitation disease trials by phase

About Aortic Regurgitation Disease Clinical Trials

Looking for clinical trials for Aortic Regurgitation Disease? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Aortic Regurgitation Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Aortic Regurgitation Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Artificial Intelligence in Aortic Regurgitation

Aortic Regurgitation Disease
Chinese University of Hong Kong540 enrolled1 locationNCT07486271
Recruiting

Noninvasive Real-Time Arterial Waveform Monitoring for Cardiovascular Disease Assessment

Healthy SubjectsAortic Stenosis DiseaseAortic Regurgitation Disease
Anhui Provincial Cancer Hospital15 enrolled1 locationNCT07350629
Recruiting

The ARTEMIS Data Collection Study

Aortic Regurgitation Disease
IRCCS Policlinico S. Donato75 enrolled1 locationNCT07075861
Recruiting
Not Applicable

Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of CONTOUR Trial - a Randomized Trial

Aortic Regurgitation DiseaseBicuspid Aortic Valve (BAV)
University Hospital Augsburg100 enrolled4 locationsNCT06869954
Recruiting
Phase 4

Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.

Heart Valve DiseasesLeft Ventricle RemodelingAortic Regurgitation Disease
Vitor Emer Egypto Rosa60 enrolled1 locationNCT07099859
Recruiting

Impact of Anesthesia, Positive Pressure Ventilation and Modality of Imaging on the Echocardiographic Assessment of the Severity of Aortic Regurgitation

Aortic Regurgitation DiseaseAortic Insufficiency
University of Liege100 enrolled1 locationNCT06835946
Recruiting
Not Applicable

Valvular Assessment of New Generation Aortic Replacement Devices

Aortic Regurgitation DiseaseAortic Valve CalcificationBicuspid Aortic Valve Disease
Instituto Dante Pazzanese de Cardiologia200 enrolled1 locationNCT06688448